NCT01354145 - Study of the Effect of Chondroitin Sulfate on Structural Changes in Knee Osteoarthritis Patients Assessed by MRI | Biotech Hunter

Enrollment

194

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

September 30, 2014

Study Completion Date

October 31, 2014

Conditions

Knee Osteoarthritis

Interventions

DRUG

Chondroitin sulfate

Chondroitin sulphate 1200 mg/day, 24 months treatment period

DRUG

Celecoxib

Celecoxib 200 mg/day, 24 months treatment period

Trial Locations (5)

Institut de Rhumatologie de Montréal, Montreal

Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal

Groupe de Recherche en rhumatologie et maladies osseoues, Québec

Centre de Rhumatologie St. Louis, Sante Foi

Centre de Recherche musculo-squellettique, Trois-Rivières